Transnail drug delivery device:A prominent approach for Onychomycosis therapy

  • Zeeant Iqbal Associate Professor
  • Nazia Hassan
  • Rahmuddin Khan

Abstract

Onychomycosis is often challenging therapeutically and demands a multipronged approach both in terms of systemic as well as topical delivery. The conventional treatment modalities available for onychomycosis are marred with challenges such as low permeation, infection reoccurrence and resistance development. Henceforth, the current article explores the concept of a Transnail drug-delivery device as a promising tool offering high clinical potential and aesthetic suitability against onychomycosis.

Keywords: Onychomycosis, Transnail, Nail Lacquer, Trichophyton rubrum

Downloads

Download data is not yet available.

References

1. Murdan S, Hinsu D and Guimier M. A few aspects of transonychial water loss (TOWL): inter-individual,
and intra-individual inter-finger, inter-hand and inter-day variabilities, and the influence of nail plate hydration, filing and varnish. Eur J Pharm Biopharm. 2008; 70:6849. DOI: 10.1016/j.ejpb.2008.05.018
2. Elewski BE. Onychomycosis: pathogenesis, diagnosis, and management. Clin Microbiol Rev. [Internet]. 1998 [cited 2018 Oct 20]; 11(3):415-29.
3. Onychomycosis.JPG [Internet]. 2009 Jun 27 [cited 2018 Oct 18]. Available from:
https://commons.m.wikimedia.org/wiki/File:Onychomycosis.JPG
4. Gupta AK, Simpson FC. New pharmacotherapy for the treatment of onychomycosis: an update. Expert Opin Pharmacother. 2015; 16(2):227-36.
5. Iorizzo M, Piraccini BM, Tosti A. Today’s treatments options for onychomycosis.J Dtsch Dermatol Ges. 2010; 8(11):875-9.
6. Onychomycosis nailed Leelavathi M, Noorlaily MN. Onychomycosis nailed. Malays Fam Physician. 2014; 9(1):2-7.
7. Alley MR, Baker SJ, Beutner KR and Plattner J. Recent progress on the topical therapy of onychomycosis. Expert Opin Investig Drugs. 2007; 16:157-67.
Zeenat et.al. International Journal of Drug Regulatory Affairs. 2018; 6(4):42-45
e-ISSN: 2321-6794 [45]
8. Shivakumar HN, Juluri A, Desai BG and Murthy SN. Ungual and transungual drug delivery. Drug Dev Ind Pharm. 2012; 38:901-11.
9. Murdan S. Drug delivery to the nail following topic1al application. Int J Pharm. 2002; 236:1-26.
10. Akhtar N, Sahu S, Pathak K. Antifungal potential of tolnaftate against Candida albicans in the treatment of onychomycosis: development of nail lacquer and ex vivo characterization. PBR. 2016; 2(3):1-2. DOI: 10.18869/acadpub.pbr.2.3.1
11. Hussan SD, Santanu R, Devina S, Vishal B, Manmohan S. Transungual drug delivery-a novel approach of unique features. Am. j. pharm. Res. 2013; 3(6).
12. Hasan N, Singh M, Sulaiman S, Nandy S, Dudeja M, Ali A, Iqbal Z. Design, development and optimization of a transungual duple nail lacquer for onychomycosis therapy. Journal of the J Eur Acad Dermatol Venereol. 2018 Jun; 32(6): e250-1.
Statistics
44 Views | 70 Downloads
How to Cite
Iqbal, Z., N. Hassan, and R. Khan. “Transnail Drug Delivery Device:A Prominent Approach for Onychomycosis Therapy”. International Journal of Drug Regulatory Affairs, Vol. 6, no. 4, Dec. 2018, pp. 42-45, doi:https://doi.org/10.22270/ijdra.v6i4.285.